SEC Filing Summary: Astro-Med, Inc. (8-K)
Business Context and Reporting Period
This Form 8-K was filed by Astro-Med, Inc. on May 19, 2009. The filing serves as a Current Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. The primary purpose of this report is to disclose remarks made by Albert W. Ondis, Chairman and Chief Executive Officer, at the Company's Annual Meeting of Shareholders held on the same date.
Financial Metrics
The filing text does not provide specific financial data. No values for revenue, profit, cash flow, margins, debt, or liquidity are included in this document. The report references an exhibit containing the CEO's remarks but does not reproduce the financial figures within the body of the 8-K.
Material Changes
The filing does not detail specific material changes in financial performance or operations compared to prior periods. It solely references the delivery of shareholder remarks as the event being reported.
Guidance, Outlook, and Risks
While the filing incorporates the CEO's remarks by reference (Exhibit 99.1), the text of the 8-K itself does not contain specific guidance, outlook, management commentary, risks, or contingencies. The document explicitly states that the information is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Key Facts for Investor Verification
- Verify the content of Exhibit 99.1 (Remarks of Albert W. Ondis) for actual financial commentary, strategic updates, or guidance, as these details are not present in the 8-K summary text.
- Confirm the date of the Annual Meeting of Shareholders was May 19, 2009.
- Note that the registrant is Astro-Med, Inc., incorporated in Rhode Island, with principal executive offices in West Warwick, RI.
- Understand that this filing is a procedural disclosure of a public event rather than a source of new quantitative financial data.